Telix Pharmaceuticals (NasdaqGS:TLX) Earnings Call Presentation

The future of prostate cancer imaging: What do physicians want? March 5, 2026 ASX: TLX | Nasdaq: TLX Forward looking statement This presentation should be read together with our risk factors, as disclosed in our most recently filed reports with the Australian Securities Exchange (ASX), U.S. Securities and Exchange Commission (SEC), including our Annual Report on Form 20-F filed with the SEC, or on our website. The information contained in this presentation is not intended to be an offer for subscription, in ...